MedPath

BAROSENSE, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 1:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 1
1 (50.0%)

Safety and Preliminary Effectiveness of the BaroSense Articulating Circular Endoscopic (ACE) Stapler for Plication of Dilated Post-surgical Gastric Anatomy

Not Applicable
Withdrawn
Conditions
Obese
First Posted Date
2011-07-07
Last Posted Date
2012-02-08
Lead Sponsor
BaroSense Inc.
Registration Number
NCT01388673

Multi-Center Feasibility Study of Trans-oral Endoscopic Restrictive Implant System (TERIS) for Treatment of Obesity

Phase 1
Completed
Conditions
Obesity
First Posted Date
2008-07-01
Last Posted Date
2013-04-10
Lead Sponsor
BaroSense Inc.
Target Recruit Count
40
Registration Number
NCT00707720
Locations
🇨🇦

Hopital Laval, Quebec City, Quebec, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.